Home › Non-Muscle Invasive Bladder Cancer › California › Bakersfield
Non-Muscle Invasive Bladder Cancer clinical trials in Bakersfield, CA
5 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Bakersfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RecruitingPhase 2
- Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
RecruitingPhase 1/2
- Michael G Oefelein Clinical Trials ( Site 0053), Bakersfield
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 2
- Michael Oefelein Clinical Trials, Bakersfield
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
RecruitingPhase 3
- Michael Oefelein Clinical Trials, Bakersfield
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
RecruitingPhase 1/2
- Unio Specialty Care - A Genesis Healthcare Partners Facility, Bakersfield
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Philadelphia, PA7 studies
- Birmingham, AL7 studies
Other studies in Bakersfield
- Bladder Cancer7 studies
- Breast Cancer4 studies
- Asthma4 studies
- Cancer (all types)3 studies
- Colorectal Cancer3 studies
- Carcinoma in Situ3 studies
- Macular Degeneration3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.